MedPath

Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

Completed
Conditions
Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Registration Number
NCT00179075
Lead Sponsor
Vanderbilt University
Brief Summary

This is a repository to store blood and stem cell samples for future research.

Detailed Description

Our Hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of GVHD by determining the qualitative and quantitative changes in T regulatory cells throughout the transplant process. Our understanding of this can lead to new treatment strategies and improved clinical therapeutic implications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients 18-70 years old undergoing either autologous transplant or allogeneic transplant for various hematologic conditions
Exclusion Criteria
  • Patients < 18 or > 70 years old undergoing either autologous transplant or allogeneic transplant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath